Trametinib 3
Contact us: [email protected]
Trametinib |
|||
| abx283095-100g | Abbexa | 100 µg | Ask for price |
Trametinib |
|||
| abx283095-20g | Abbexa | 20 µg | EUR 106.25 |
Trametinib |
|||
| abx283095-50g | Abbexa | 50 µg | EUR 237.5 |
Trametinib |
|||
| GP2302 | Glentham Life Sciences | 10mg | EUR 130.36 |
Trametinib |
|||
| GP2302-10 | Glentham Life Sciences | 10 | EUR 142.4 |
Trametinib |
|||
| GP2302-10MG | Glentham Life Sciences | 10 mg | EUR 418.8 |
Trametinib |
|||
| HY-10999 | MedChemExpress | 100mg | EUR 465.38 |
|
Description: Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
|||
Trametinib |
|||
| MBS3606330-100mg | MyBiosource | 100mg | EUR 245 |
Trametinib |
|||
| MBS3606330-10mg | MyBiosource | 10mg | EUR 200 |
Trametinib |
|||
| MBS3606330-200mg | MyBiosource | 200mg | EUR 275 |
Trametinib |
|||
| MBS3606330-50mg | MyBiosource | 50mg | EUR 215 |
Trametinib |
|||
| MBS3606330-5x200mg | MyBiosource | 5x200mg | EUR 920 |
Trametinib |
|||
| T2125-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Trametinib |
|||
Trametinib |
|||
| T2125-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Trametinib |
|||
Trametinib |
|||
| T2125-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Trametinib |
|||
Trametinib |
|||
| T2125-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Trametinib |
|||
Trametinib |
|||
| T2125-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Trametinib |
|||
Trametinib-13C6 |
|||
| C988931 | Toronto Research Chemicals | 0.5mg | EUR 4669 |
Trametinib-13C6 |
|||
| HY-10999S1 | MedChemExpress | 1mg | Ask for price |
|
Description: Trametinib-13C6 is the 13C-labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
|||
Trametinib-13C,d3 |
|||
| HY-10999S2 | MedChemExpress | 1mg | EUR 1007.59 |
|
Description: Trametinib-13C,d3 is the 13C- and deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
|||
Trametinib [CAS# 871700-17-3] |
|||
| T-8123 | LC LABORATORIES | 10 mg | EUR 38 |
Trametinib-d4 |
|||
| HY-10999S | MedChemExpress | 1mg | Ask for price |
|
Description: Trametinib-d4 is the deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
|||
Trametinib-d4 |
|||
| T712602 | Toronto Research Chemicals | 100mg | EUR 4500 |
Deiodo Trametinib |
|||
| D397050 | Toronto Research Chemicals | 100mg | EUR 800 |
|
Description: 871700-65-1 |
|||
Trametinib (GSK1120212) |
|||
| A3018-200 | ApexBio | 200 mg | EUR 153.6 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib (GSK1120212) |
|||
| A3018-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib (GSK1120212) |
|||
| A3018-50 | ApexBio | 50 mg | EUR 76.8 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib (GSK1120212) |
|||
| A3018-500 | ApexBio | 500 mg | EUR 324 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib (GSK1120212) |
|||
| A3018-S | ApexBio | Evaluation Sample | EUR 24 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib (GSK1120212) |
|||
| MBS576333-100mg | MyBiosource | 100mg | EUR 180 |
Trametinib (GSK1120212) |
|||
| MBS576333-10mg | MyBiosource | 10mg | EUR 145 |
Trametinib (GSK1120212) |
|||
| MBS576333-200mg | MyBiosource | 200mg | EUR 210 |
Trametinib (GSK1120212) |
|||
| MBS576333-50mg | MyBiosource | 50mg | EUR 155 |
Trametinib (GSK1120212) |
|||
| MBS576333-5mg | MyBiosource | 5mg | EUR 130 |
Trametinib DMSO solvate |
|||
| 123211 | MedKoo Biosciences | 10.0mg | EUR 90 |
Trametinib DMSO solvate |
|||
| A3887-10 | ApexBio | 10 mg | EUR 40 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib DMSO solvate |
|||
| A3887-100 | ApexBio | 100 mg | EUR 95.2 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib DMSO solvate |
|||
| A3887-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib DMSO solvate |
|||
| A3887-50 | ApexBio | 50 mg | EUR 64 |
|
Description: MAPK Signaling|MEK1/2 |
|||
Trametinib (DMSO solvate) |
|||
| HY-10999A | MedChemExpress | 100mg | EUR 75.76 |
|
Description: Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate);JTP-74057 (DMSO solvate)) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib (DMSO solvate) activates autophagy and induces apoptosis[1][2]. |
|||
Trametinib DMSO solvate |
|||
| MBS5752199-100mg | MyBiosource | 100mg | EUR 180 |
Trametinib DMSO solvate |
|||
| MBS5752199-10mg | MyBiosource | 10mg | EUR 145 |
Trametinib DMSO solvate |
|||
| MBS5752199-200mg | MyBiosource | 200mg | EUR 225 |
Trametinib DMSO solvate |
|||
| MBS5752199-25mg | MyBiosource | 25mg | EUR 145 |
Trametinib DMSO solvate |
|||
| MBS5752199-50mg | MyBiosource | 50mg | EUR 160 |
Trametinib (DMSO solvate) |
|||
| MBS3845880-100mg | MyBiosource | 100mg | EUR 425 |
Trametinib (DMSO solvate) |
|||
| MBS3845880-10mg | MyBiosource | 10mg | EUR 140 |
Trametinib (DMSO solvate) |
|||
| MBS3845880-25mg | MyBiosource | 25mg | EUR 200 |
Trametinib (DMSO solvate) |
|||
| MBS3845880-50mg | MyBiosource | 50mg | EUR 275 |
Trametinib (DMSO solvate) |
|||
| MBS3845880-5x100mg | MyBiosource | 5x100mg | EUR 1910 |
Trametinib DMSO solvate |
|||
| MBS3600640-100mg | MyBiosource | 100mg | EUR 245 |
Trametinib DMSO solvate |
|||
| MBS3600640-10mg | MyBiosource | 10mg | EUR 200 |
Trametinib DMSO solvate |
|||
| MBS3600640-200mg | MyBiosource | 200mg | EUR 290 |
Trametinib DMSO solvate |
|||
| MBS3600640-25mg | MyBiosource | 25mg | EUR 200 |
Trametinib DMSO solvate |
|||
| MBS3600640-50mg | MyBiosource | 50mg | EUR 220 |
Trametinib Impurity-I |
|||
| T138340 | Toronto Research Chemicals | 10mg | EUR 800 |
|
Description: 1383430-03-2 |
|||
Trametinib (DMSO Solvate) |
|||
| T314310 | Toronto Research Chemicals | 100mg | EUR 800 |
|
Description: 1187431-43-1 |
|||
Trametinib (DMSO solvate) |
|||
| T5857-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Trametinib (DMSO solvate) |
|||
Trametinib (DMSO solvate) |
|||
| T5857-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Trametinib (DMSO solvate) |
|||
Trametinib (DMSO solvate) |
|||
| T5857-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Trametinib (DMSO solvate) |
|||
Trametinib (DMSO solvate) |
|||
| T5857-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Trametinib (DMSO solvate) |
|||
Trametinib (DMSO solvate) |
|||
| T5857-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Trametinib (DMSO solvate) |
|||
OOMC00081-10MG - Trametinib |
|||
| OOMC00081-10MG | Aviva Systems Biology | 10mg | EUR 59 |
OOMC00081-50MG - Trametinib |
|||
| OOMC00081-50MG | Aviva Systems Biology | 50mg | EUR 199 |
Trametinib dimethyl sulfoxide |
|||
| 414033 | MedKoo Biosciences | 25.0mg | EUR 228 |
GSK1120212 (JTP-74057, Trametinib) |
|||
| MBS384815-100mg | MyBiosource | 100mg | EUR 210 |
GSK1120212 (JTP-74057, Trametinib) |
|||
| MBS384815-10mg | MyBiosource | 10mg | EUR 145 |
GSK1120212 (JTP-74057, Trametinib) |
|||
| MBS384815-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 145 |
GSK1120212 (JTP-74057, Trametinib) |
|||
| MBS384815-50mg | MyBiosource | 50mg | EUR 170 |
GSK1120212 (JTP-74057, Trametinib) |
|||
| MBS384815-5mg | MyBiosource | 5mg | EUR 130 |
Trametinib, DMSO Solvate [CAS# 1187431-43-1] |
|||
| T-8188 | LC LABORATORIES | 10 mg | EUR 38 |
Trametiglue |
|||
| HY-153181 | MedChemExpress | 10 mg | EUR 2380.99 |
|
Description: Trametiglue, a derivative of Trametinib (HY-10999), targets both KSR-MEK and RAF-MEK with unprecedented potency and selectivity via unique interfacial binding interactions[1]. |
|||
Recombinant Trametes villosa Laccase-3 (LCC3) |
|||
| MBS1290994-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1230 |
Recombinant Trametes villosa Laccase-3 (LCC3) |
|||
| MBS1290994-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 1010 |
Recombinant Trametes villosa Laccase-3 (LCC3) |
|||
| MBS1290994-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 1115 |
Recombinant Trametes villosa Laccase-3 (LCC3) |
|||
| MBS1290994-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1310 |
Recombinant Trametes villosa Laccase-3 (LCC3) |
|||
| MBS1290994-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1445 |
Trametol |
|||
| MBS5791091-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Trametol |
|||
| T125618-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Trametol |
|||
Trametol |
|||
| T125618-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Trametol |
|||
Trametol |
|||
| T125618-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Trametol |
|||
Trametol |
|||
| T125618-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Trametol |
|||
Trametol |
|||
| T125618-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Trametol |
|||
Trametenolic acid |
|||
| MBS5760986-1mg | MyBiosource | 1mg | EUR 320 |
Trametenolic acid |
|||
| MBS5760986-5x1mg | MyBiosource | 5x1mg | EUR 1290 |
Trametenolic acid |
|||
| TN2280-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Trametenolic acid |
|||